NKTR
Nektar Therapeutics
Price:  
0.68 
USD
Volume:  
966,732.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NKTR EV/EBITDA

-1913.7%
Upside

As of 2024-02-25, the EV/EBITDA ratio of Nektar Therapeutics (NKTR) is -0.48. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NKTR's latest enterprise value is 65.28 mil USD. NKTR's TTM EBITDA according to its financial statements is -136.10 mil USD. Dividing these 2 quantities gives us the above NKTR EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.5x - 18.2x 13.6x
Forward P/E multiples 17.1x - 25.4x 22.0x
Fair Price (11.89) - (12.64) (12.38)
Upside -1842.1% - -1952.9% -1913.7%
0.68 USD
Stock Price
(12.38) USD
Fair Price

NKTR EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-23 -0.44
2024-02-22 -0.43
2024-02-21 -0.45
2024-02-20 -0.43
2024-02-16 -0.46
2024-02-15 -0.48
2024-02-14 -0.50
2024-02-13 -0.43
2024-02-12 -0.46
2024-02-09 -0.46
2024-02-08 -0.45
2024-02-07 -0.44
2024-02-06 -0.44
2024-02-05 -0.36
2024-02-02 -0.36
2024-02-01 -0.38
2024-01-31 -0.35
2024-01-30 -0.36
2024-01-29 -0.36
2024-01-26 -0.33
2024-01-25 -0.33
2024-01-24 -0.33
2024-01-23 -0.33
2024-01-22 -0.33
2024-01-19 -0.35
2024-01-18 -0.36
2024-01-17 -0.32
2024-01-16 -0.34
2024-01-12 -0.35
2024-01-11 -0.35
2024-01-10 -0.36
2024-01-09 -0.36
2024-01-08 -0.38
2024-01-05 -0.35
2024-01-04 -0.37
2024-01-03 -0.36
2024-01-02 -0.39
2023-12-29 -0.37
2023-12-28 -0.36
2023-12-27 -0.33
2023-12-26 -0.34
2023-12-22 -0.33
2023-12-21 -0.31
2023-12-20 -0.31
2023-12-19 -0.31
2023-12-18 -0.32
2023-12-15 -0.30
2023-12-14 -0.34
2023-12-13 -0.32
2023-12-12 -0.30